← Human Trials & Peer-Reviewed Studies

Vitamin D Supplementation, Chronic Obstructive Lung Disease and Asthma Exacerbations, and Lung Function Decline.

Plain-language guide to PMID 39922497 (2025): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 50 women.

Key Facts

PMID
39922497
Journal
The Journal of nutrition
Year
2025
Study type
Randomized Controlled Trial
Authors
Gold DR et al. (11 authors)
DOI
10.1016/j.tjnut.2025.02.003
Registered trial
NCT01728571

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

To compare effects of vitamin D with placebo supplementation for the prespecified primary endpoints 1) acute exacerbations of COPD and 2) decline in pulmonary function measures of airflow obstruction.

Prespecified secondary endpoints included asthma exacerbations and control.

Who Took Part

According to the abstract, 50 women were involved.

PubMed indexes the participants as middle-aged adults and older adults, both men and women.

Of 25,871 randomly divided participants, 3632 at risk for respiratory exacerbations, including 1977 with COPD by diagnosis or symptoms and 1654 with self-reported asthma diagnosis, were followed annually for 5 y by self-administered respiratory questionnaire.

Spirometry was performed at baseline and 2 y after randomization by 1648 participants from 12 urban centers.

How the Study Was Run

In design terms this was a randomized and placebo-controlled study.

The women were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.

The comparison arm used a placebo, so changes seen with Vitamin D, K2, Magnesium and Zinc could be set against what happens without it.

Decline in forced expiratory volume in 1 s (FEV1) and FEV1/forced vital capacity was measured between baseline and follow-up.

What Was Measured

Topics PubMed links to this paper include Pulmonary Disease, Chronic Obstructive, Asthma, Dietary Supplements, Vitamin D, Lung, Respiratory Function Tests and Cholecalciferol.

The authors tagged it with the keywords COPD, pulmonary function, spirometry and vitamin supplement.

What This Means in Plain Language

The paper is a randomized and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 50 women.

Results are reported in around 5 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2025 (The Journal of nutrition), a journal based in United States.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.